全体研究人员 学术带头人

彭涛

职称:

教授

研究方向:

重大呼吸系统感染和肺损伤

研究工作:

长期以来运用基因工程和分子生物学的手段从事针对呼吸道病毒性传染性疾病的应用基础研究,包括基因工程疫苗的设计与评价、抗病毒药物的筛选及评价手段的开发,以及基于等温快速核酸扩增技术的快速诊断技术产品等。

代表性学术论文:

1、Hu L, Jiang J, Tang Y, Mei L, Wu L, Li L, Chen H, Long F, Xiao J, Peng T* A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus. Viruses. 2023 Jul 14;15(7):1548. doi: 10.3390/v15071548.

2、Hu L, Lao G, Liu R, Feng J, Long F, Peng T* The race toward a universal influenza vaccine: Front runners and the future directions. Antiviral Res. 2022 Dec 24:105505. doi: 10.1016/j.antiviral.2022.105505.

3、Hu L, Tang Y, Mei L, Liang M, Huang J, Wang X, Wu L, Jiang J, Li L, Long F, Xiao J, Tan L, Lu S, Peng T* A new intracellular targeting motif in the cytoplasmic tail of the spike protein may act as a target to inhibit SARS-CoV-2 assembly. Antiviral Res. 2022 Dec 24;209:105509. doi: 10.1016/j.antiviral.2022.105509.

4、Jiang J, Du Y, Peng T*. SARS-CoV-2 Omicron Variant is Expected to Retain Most of the Spike Protein Specific Dominant T-Cell Epitopes Presented by COVID-19 Vaccines - Worldwide, 2021 China CDC Wkly. 2022 May 6;4(18):381-384. doi: 10.46234/ccdcw2022.065.

5、Hu L, Xu Y, Wu L, Feng J, Zhang L, Tang Y, Zhao X, Mai R, Chen L, Mei L, Tan Y, Du Y, Zhen Y, Su W, Peng T*. The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice Viruses. 2022 Apr 21;14(5):854. doi: 10.3390/v14050854.

6、Li X, Peng T*. Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery Front Pharmacol. 2021 May 4;12:660710. doi: 10.3389/fphar.2021.660710.

7、Du Y, Xu Y, Feng J, Hu L, Zhang Y, Zhang B, Guo W, Mai R, Chen L, Fang J, Zhang H, Peng T*. Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse Vaccine. 2021 Apr 15;39(16):2280-2287. doi: 10.1016/j.vaccine.2021.03.006.

8、Ting Li, Tao Peng* Traditional Chinese Herbal Medicine as a source of molecules with antiviral activity Antiviral Research. 2013 Jan;97(1):1-9.

联系方式:

Email: pengtao@gzhmu.edu.cn